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Introduction
Pelvic lymph node dissection (PLND) has a role in
the treatment of several genitourinary cancers. The
pathological stage and grade of the bladder tumour and the
presence of lymph node metastasis are the most important
determinants of survival in patients with bladder cancer
undergoing radical cystectomy.1,2 There has been a
continuous search for reliable methods for preoperative
assessment of lymph node status. Lymphangiography with
fine needle aspiration has been evaluated in several
studies, but it is not reliable due to a high false-negative
rate.3 Preoperative imaging studies like computed
tomography (CT) was investigated to determine its
capacity to detect lymph node metastases in bladder
cancer and the results have been largely disappointing
with a high (21%) false-negative rate observed.4 In
addition, results with positron emission tomography (PET)
are not very promising either.5
Despite an early and aggressive approach towards
high-grade invasive bladder cancer,6 nearly 25% of patients
demonstrate pathologic evidence of lymph node metastases
at the time of cystectomy.7 Radical cystectomy is
considered the standard of care in the management of high
grade and muscle invasive bladder cancer. Bilateral pelvic
lymphadenectomy is now considered as an essential part of
the radical cystectomy for bladder cancer. There is little
debate regarding the benefits of a lymph node dissection.
The combination provides excellent local control and long
term survival for most patients with >pT2 cancer.8 It is not
only important for accurate staging but may also have a
therapeutic benefit in terms of reducing loco regional
recurrence. The limited lymph node dissection is generally
described as an extirpation of the lymphatic tissue in the
obturator fossa.9 Another method of dissection is standard
dissection10 includes the area stretching laterally as far as
the genito-femoral nerve, medially to the base of bladder
and posteriorly to the bifurcation of common iliac vessels.
Operative technique referred to as an extended nodal
dissection11,12 has the cranial boundary of
lymphadenectomy extended to the aortic bifurcation or even
up to the inferior mesenteric artery (IMA). 
Lymph node involvement is associated with
increased risk of local recurrence and disease progression
with survival rates varying from 20% to 40% in patients
with and without lymph node metastasis respectively.13,14
The practice of lymphadenectomy is not standardized.
Data from one centre showed that the number of nodes
retrieved per patient could vary from 0-53.15 Recent
evidence suggests that both the number of nodes
removed8 and method of submission of nodal specimen16
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Abstract
Objective: To identify the clinical variables associated with prevalence of lymph node metastasis in patients with
bladder cancer treated by radical cystectomy and lymphadenectomy for primary bladder cancer.
Methods: Review of records of Ninety-five patients who underwent radical cystectomy and pelvic lymph node
(LN) dissection during the period of 1995-2008 from a prospectively maintained database. Eighteen patients
were excluded due to lack of data on the nodal status, leaving 77 evaluable patients. Associations between LN
metastasis and age, gender, duration of disease, number of transurethral resection (TUR) prior to cystectomy,
pathological grade and tumour stage was analyzed. Data was analyzed using the SPSS software, version 15.
Statistical tests applied were independent sample t test or the Mann Whitney U test, the chi-square test and the
Fischer exact test. 
Results: The median age of the patients was 58 years in lymph node negative group and 63 years in lymph node
positive group. There were 87% males and 13% females. LN metastasis was detected in 19 (25%) patients.
Mean duration of disease in LN negative patients was 537±997 days compared to 509±708 days in LN positive
patients. Mean number of TUR were same in both the groups, pathological grade was not found significantly
different in both groups, where as primary tumour stage was found to be significantly (p<0.05) higher in LN
positive patients. 
Conclusions: Higher primary tumour stage at radical cystectomy is associated with higher prevalence of lymph
node metastasis (JPMA 59:516; 2009).
affect the patient outcome.
Invasive bladder tumours tend to invade
progressively from their superficial origin in the mucosa to
the lamina propria and sequentially into the muscularis
propria, perivesical fat, and contiguous pelvic organs, with
an increasing incidence of lymph node involvement at each
site. A surgically positive lymph node in invasive bladder
cancer generally implies distant micro-metastasis; thus,
preoperative identification of lymph node status is
important. Various anti-oncoproteins were evaluated for
their accuracy in predicting lymph node metastasis.17 The
current work evaluates the practice of nodal dissection and
the variables affecting nodal metastasis during radical
cystectomy.  
Methods
Between 1995 and 2008, 95 patients underwent
radical cystectomy for primary bladder cancer. The hospital
is in the private sector and not a referral centre for
oncological surgery.  It has three trained oncological
urologists and all types of urinary diversions including
orthotopic bladder replacements are performed. Tumour
staging was performed using TNM (T, tumor stage i.e. T0-
T4; N, nodal stage N0-N2; M, metastases i.e. Mx M1-2)
staging system. Grading was done according to the
classification of the World Health Organization (WHO)
published in 1973 (WHO 1973) includes urothelial
papilloma and three grades of papillary carcinoma (grade 1,
or G1; grade 2, or G2; and grade 3, or G3).18 In case of
pathological evidence prefix of small p is added (e.g. pT2).
Eighteen patients (19%) patients had lack of data on
nodal status and were excluded. Patients were stratified
according to the presence or absence of lymph node (LN)
metastasis at the time of radical cystectomy. The prevalence
of lymph node metastasis was correlated with age, gender,
number of transurethral resections (TURBTs), duration of
disease (from diagnosis to Radical cystectomy), tumour
grade, stage of the tumour at radical cystectomy and type of
lymphadenectomy. Data were analyzed using the SPSS
software (Statistical Package for the Social Sciences,
version 15.0, SPSS Inc, and Chicago, Ill, USA). Continuous
variables were compared between the groups using the
independent sample t test or the Mann Whitney U test. The
chi-square test and the Fischer exact test were used to
compare categorical and dichotomous variables. A P value
less than 0.05 was considered significant. 
Results
Of the 95 patients, 18 were excluded due to lack of
information on the pathological evaluation of the lymph
nodes (Figure). There was significant male dominance in
the series (male 87%, female 13%). Median age of the
patients was 58 years in lymph node negative group and 63
years in lymph node positive group which was not
significant statistically. Out of 77 evaluable patients',
pathologically nodal positive were 19 (25%) (Table-1). 
Mean duration of disease in LN negative patients
was 537±997 days compared to 509±708 days in LN
positive patients, mean number of transurethral resections
were 1.43±0.5 in node negative, and 1.42±0.6 in node
positive group (Table-2). The association of the grade of
tumour at radical cystectomy showed that out of 18 patients
with G1-2 lesion only 3 (16.6%) had lymph node
metastasis, of the 59 patients with G3 lesion, 10 (27%) had
lymph node metastasis, though lymph node positivity
increases as the grade increases but the difference is not
statically significant  (p 0.538). Most of the patients had pT2
(51%) disease. None of the 10 patients with pT0-1 had
positive nodes. Eight (20.5%) of 39 patients with pT2
disease had positive nodes, however, 11 (39.2%) out of 28
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Figure: Patient's distribution according to the lymph node status.
Table 1: Difference in the nodal positivity in relation to gender,
tumor stage, grade and type of lymphadenectomy.
Lymph Node status
Negative (n = 58) Positive (n =
19)
n % n %
Gender 
(p-value=0.701) Male 51 87.9% 16 84.2%
Female 7 12.1% 3 15.8%
Primary Tumour Stage T0 7 12.1% 0 .0%
(p-value<0.05) T1 3 5.2% 0 .0%
T2 31 53.4% 8 42.1%
T3 9 15.5% 6 31.6%
T4 8 13.8% 5 26.3%
TCC Grade 
(p-value=0.538) G1 1 1.7% 0 .0%
G2 14 24.1% 3 15.8%
G3 43 74.1% 16 84.2%
Type of Standard (n=34) 24 41.4% 10 52.6%
lymphadenectomy
(p-value=0.434) En bloc (n=43) 34 58.6% 9 47.4%
patients had positive nodes in stage pT3-4 disease (p <0.05).
lymph node positivity was higher in patient who underwent
standard lymphadenectomy as compare to en block
dissection 29% vs. 21% (p-value=0.434).
Discussion
Lymph node (LN) metastasis is seen in 14 to 28% of
patients who undergo pelvic lymphadenectomy during
radical cystectomy for bladder cancer.6,7 LN metastasis is
associated with an increased risk of local recurrence,
regional disease progression and overall poorer outcome.
Extended and standard lymphadenectomy is not only
important in accurate disease staging but also provides
direct survival benefit. The importance of nodal dissection
with therapeutic intent is increasingly realized. Recent
evidence has shown that node positive disease is a
significant and independent prognostic factor. Imaging
studies are not reliable in predicting nodal involvement
prior to surgery, therefore other predictors could help in
designing management plan. Duration of disease, number of
TUR, age of the patient, stage and grade at cystectomy as
predictors of nodal disease were analyzed. In the small
cohort studied, primary tumour stage was found to have
statistically significant association with nodal disease.  
The absolute boundaries of lymphadenectomy
remain a subject of controversy. Abol Enien and
colleagues11 noted that in extended lymphadenectomy there
is 37% bilateral and 60% unilateral node positive disease.
Dissection of only internal iliac nodes will miss 85%
positive nodes, whereas dissection of internal, external iliac
and Obturator nodes will identify 2/3rd of the nodes
whereas dissection up the aortic bifurcation locates 4/5th of
the nodes. A recent study has shown that compared to en
bloc resection, standard lymphadenectomy increases the
nodal yield and node positive disease.18
The guidelines published in March 2008 for the
treatment of muscle invasive bladder cancer by The
European Association of Urology recommends
lymphadenectomy as an integral part of radical cystectomy
but the extent of lymphadenectomy is not established
yet.9,13,19 This consists of removing the tissue in the
Obturator fossa in patients undergoing surgery with a
curative intent. Several authors have noted an improved 5-
year survival with extensive pelvic lymph node dissection in
patients with node positive bladder cancer.1,19,20 Herr and
colleagues8 examined whether the number of nodes removed
would affect outcomes after radical cystectomy. These
investigators found that a minimum of nine nodes needed to
be examined to accurately assess nodal status. They also
found that survival improved in both node positive and node-
negative patients as the number of nodes removed increased.
The same investigators evaluated the impact of submitting
nodes en bloc or as separate packages and suggested that
submitting nodes as separate packages not only is easier but
also optimizes the evaluation and number of the lymph
nodes retrieved. Some studies indicate that
lymphadenectomy, in combination with radical cystectomy
— can cure a small fraction of node-positive patients.14
Conclusion 
The current work indicates that although grade of
tumour and mean age of the patient at radical cystectomy
have a positive association with node positive disease, it is
not statistically significant, due perhaps to the small number
of patients. Among analyzed variables, only primary tumour
stage was found significantly different in lymph node
positive and lymph node negative group. 
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